FGF2 and neoplasm: Exosomal miR-503 modifies the tumor microenvironment and blocks the angiogenetic process by simultaneously perturbing the expression of two potent pro-angiogenetic molecules, fibroblast growth factor 2 (FGF2) and VEGFA [114].